Correction: Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer

por Kang, Yun Pyo, Torrente, Laura, Falzone, Aimee, Elkins, Cody M, Liu, Min, Asara, John M, Dibble, Christian C, DeNicola, Gina
Publicado 2019

Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer

por Kang, Yun Pyo, Torrente, Laura, Falzone, Aimee, Elkins, Cody M, Liu, Min, Asara, John M, Dibble, Christian C, DeNicola, Gina M
Publicado 2019

Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors

por Crawford, McKenna C., Tripu, Deepika R., Barritt, Samuel A., Jing, Yihang, Gallimore, Diamond, Kales, Stephen C., Bhanu, Natarajan V., Xiong, Ying, Fang, Yuhong, Butler, Kamaria A. T., LeClair, Christopher A., Coussens, Nathan P., Simeonov, Anton, Garcia, Benjamin A., Dibble, Christian C., Meier, Jordan L.
Publicado 2023

PI3K drives the de novo synthesis of coenzyme A from vitamin B5

por Dibble, Christian C., Barritt, Samuel A., Perry, Grace E., Lien, Evan C., Geck, Renee C., DuBois-Coyne, Sarah E., Bartee, David, Zengeya, Thomas T., Cohen, Emily B., Yuan, Min, Hopkins, Benjamin D., Meier, Jordan L., Clohessy, John G., Asara, John M., Cantley, Lewis C., Toker, Alex
Publicado 2022